StockVS

NASDAQ · USD

Aspire Biopharma Holdings, Inc. (ASBPW) Stock Analysis

Aspire Biopharma Holdings, Inc. (ASBPW) is a stock listed on NASDAQ and quoted in US Dollar.

ASBPW

$0.02

$0.00 (0.00%)

Sep 1, 2026 · Market close

This is a derivative instrument — a warrant on Aspire Biopharma Holdings, Inc. (ASBP) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View ASBP →

Price History

Hover for the daily close. The dotted line marks the period open.

ASBPW Key Statistics

As of Sep 1, 2026
Trading
Open
$0.04
Previous Close
$0.02
Day's Range
0.02–0.02
52-Week Range
0.02–0.02
Volume
100
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.17

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ASBPW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−50.00%
2025 (partial year)+0.00%

As of September 1, 2026.

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

Visit website →